What is PROSper?
PROSper is a prospective cohort study of women with BRCA 1/2 mutations who have elected to either undergo risk reducing salpingo-oophorectomy (RRSO) or nonsurgical management.
Why is this study being done?
This goal of this study is to understand differences in health among women with a BRCA gene who decide to have surgery to remove their ovaries and fallopian tubes compared with women who decide not to have this surgery.
Want to find out more about PROSper?
If you are interested in learning more, please contact our research coordinators at 415-297-3114 or email@example.com.